Rankings
▼
Calendar
CGEM FY 2022 Earnings — Cullinan Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
CGEM
Cullinan Therapeutics, Inc.
$894M
FY 2022 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
$0
Operating Income
$145M
Net Income
$111M
EPS (Diluted)
$2.38
Cash Flow
Operating Cash Flow
-$127M
Free Cash Flow
-$128M
Stock-Based Comp.
$28M
Balance Sheet
Total Assets
$561M
Total Liabilities
$26M
Stockholders' Equity
$535M
Cash & Equivalents
$156M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$19M
-100.0%
Gross Profit
$0
$19M
-100.0%
Operating Income
$145M
-$68M
+312.9%
Net Income
$111M
-$66M
+269.6%
← Q4 2021
All Quarters
Q1 2022 →